Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 60701 | CO-1686(Rociletinib) | 1374640-70-6 | 98% | -cas-1374640-70-6.png) |
| CO-1686(Rociletinib) is an irreversible inhibitor of epidermal growth factor receptor | ||||
| 52782 | Coluracetam | 135463-81-9 | 98% |  |
| Coluracetam(MKC-231) is a new choline uptake enhancer. | ||||
| 52781 | Chenodeoxycholic Acid | 474-25-9 | 98% |  |
| Chenodeoxycholic Acid (CDCA), is a hydrophobic primary bile acid that activates nucle | ||||
| 52780 | Cerdulatinib (PRT062070, PRT2070) | 1369761-01-2 | 98% |  |
| Cerdulatinib (PRT-062070) is an oral active, multi-targeted tyrosine kinase inhibitor | ||||
| 52779 | Cediranib | 288383-20-0 |  | |
| Cediranib (AZD2171) is a highly potent VEGFR(KDR) inhibitor with IC50 of <1 nM, al | ||||
| 52778 | Cabozantinib S-malate | 1140909-48-3 | 98% |  |
| Cabozantinib S-malate (XL184, BMS-907351) is a potent VEGFR2 inhibitor with IC50 of 0 | ||||
| 52777 | Cabozantinib | 849217-68-1 | 98% |  |
| Cabozantinib (XL184, BMS-907351) is a potent VEGFR2 inhibitor with IC50 of 0.035 nM a | ||||
| 52748 | CX-5461 | 1138549-36-6 | 98% |  |
| CX-5461 is an inhibitor of rRNA synthesis, selectively inhibits Pol I-driven transcri | ||||
| 52735 | CZC24832 | 1159824-67-5 | 98% |  |
| CZC24832 is a selective inhibitor of PI 3-kinase (IC50 = 1.0 M in a PI 3-K-dependent | ||||
| 52724 | Canagliflozin | 842133-18-0 | 98% |  |
| Canagliflozin(JNJ 28431754; TA 7284) is a highly potent and selective SGLT2 inhibitor | ||||
| 52705 | CAY10603 | 1045792-66-2 | 98% |  |
| CAY10603 is a potent and selective inhibitor of HDAC6 with IC50 of 2 pM, as compared | ||||
| 52635 | CCT128930 | 885499-61-6 | 98% |  |
| CCT128930 is a novel potent ATP-competitive, selective Akt2 inhibitor with an IC50 of | ||||
| 52610 | CDK4-IN-1 | 1256963-02-6 | 98% | |
| CDK4 inhibitor is a novel and specific CDK4/Cyclin D1 inhibitor with an IC50 of 10 nM | ||||
| 52608 | Carfilzomib | 868540-17-4 | 98% |  |
| Carfilzomib (PR-171) is an irreversible proteasome inhibitor with IC50 of <5 nM. | ||||
| 52566 | CZC-54252 | 1191911-27-9 | 98% |  |
| CZC-54252 is a potent inhibitor of LRRK2 with IC50s of 1.28 nM and 1.85 nM for wild-t | ||||
| 52544 | CK-636 | 442632-72-6 | 98% |  |
| CK-636(CK-0944636) is a small molecule inhibitor of Arp2/3 complex; Inhibitor of acti | ||||
| 52534 | CYT387 | 1056634-68-4 | 98% |  |
| CYT387(momelotinib) is an ATP-competitive inhibitor of JAK1/JAK2 with IC50 of 11 nM/1 | ||||
| 52532 | CID 2011756 | 638156-11-3 | 98% |  |
| CID-2011756 is a cell-active ATP competitive and specific PKD1 inhibitor that inhibit | ||||
| 52520 | Clemizole | 476-34-6 | 98% |  |
| Clemizole is a H1 histamine receptor antagonist.Recently, researchers have identified | ||||
| 52517 | CI-994 | 112522-64-2 | 98% |  |
| CI-994 (Tacedinaline) is an anti-cancer drug which inhibits HDAC1 with IC50 of 0.57 M | ||||
| 52506 | Chidamide | 743420-02-2 | 98% |  |
| Chidamide(CS055; HBI-8000) is a class I HDAC inhibitor with IC50s of 95/160/67/733 nM | ||||
| 52502 | CCG-1423 | 285986-88-1 | 98% |  |
| CCG-1423 is a novel inhibitor of RhoA/C-mediated gene transcription that is capable o | ||||
| 52213 | CTX-0294885 | 1439934-41-4 | 98% |  |
| CTX-0294885 is a a novel bisanilino pyrimidine; exhibits inhibitory activity against | ||||
| 52234 | CX-6258 | 1202916-90-2 | 98% |  |
| CX-6258 is a potent, orally efficacious Pim 1/2/3 kinase(IC50=5 nM/25 nM/16 nM) inhib | ||||
| 52229 | CP-640186 | 591778-68-6 | 98% |  |
| CP-640186 is an isozyme-nonselective acetyl-CoA carboxylase (ACCase) inhibitor with I | ||||
| 52228 | CID-797718 | 370586-05-3 | 98% |  |
| CID-797718 is a compound with unknown details | ||||
| 51917 | CGK 733 | 905973-89-9 | 98% |  |
| CGK 733 is a potent and selective inhibitor ofATM/ATRwithIC50of ~200 nM. | ||||
| 52218 | CH-223191 | 301326-22-7 | 98% |  |
| CH-223191 is a potent and specificaryl hydrocarbon receptor (AhR)antagonist withIC50o | ||||
| 51606 | CH5424802 Hydrochloride | 1256589-74-8 | 98% |  |
| CH5424802 Hcl (AF 802 Hcl; Alectinib Hcl) is a potent ALK inhibitor with IC50 of 1.9 | ||||
| 52024 | CX-4945(Silmitasertib) | 1009820-21-6 | 98% |  |
| Silmitasertib (CX-4945) is a potent and selective orally bioavailable small molecule | ||||